1.
The subpopulation of CD105 negative mesenchymal stem cells show strong immunomodulation capacity compared to CD105 positive mesenchymal stem cells. Biomed. Res. Ther. 2019;6(4):3131-3140. doi:10.15419/bmrat.v6i4.538